V. Waldmann

710 total citations
26 papers, 528 citations indexed

About

V. Waldmann is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, V. Waldmann has authored 26 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Immunology. Recurrent topics in V. Waldmann's work include Melanoma and MAPK Pathways (8 papers), Immunotherapy and Immune Responses (6 papers) and Cutaneous Melanoma Detection and Management (5 papers). V. Waldmann is often cited by papers focused on Melanoma and MAPK Pathways (8 papers), Immunotherapy and Immune Responses (6 papers) and Cutaneous Melanoma Detection and Management (5 papers). V. Waldmann collaborates with scholars based in Germany and Norway. V. Waldmann's co-authors include Martin Deichmann, Andreas Jäckel, Michael Bock, Helmut Näher, Axel Benner, Bernhard Suchy, H. Rabes, H Näher, Sabine Klugbauer and Ulrich Keilholz and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

V. Waldmann

25 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Waldmann Germany 12 284 274 160 53 45 26 528
M Kaufmann Germany 10 240 0.8× 142 0.5× 74 0.5× 63 1.2× 47 1.0× 16 406
David W. Houck United States 10 206 0.7× 136 0.5× 183 1.1× 76 1.4× 9 0.2× 11 611
Sophie Goddard France 6 307 1.1× 276 1.0× 375 2.3× 56 1.1× 16 0.4× 7 738
Vipul Bhargava United States 12 374 1.3× 155 0.6× 237 1.5× 93 1.8× 11 0.2× 21 672
Shahryar Kiaii Sweden 11 209 0.7× 239 0.9× 279 1.7× 33 0.6× 17 0.4× 14 579
Paul W. Hollenbach United States 11 453 1.6× 92 0.3× 108 0.7× 57 1.1× 15 0.3× 13 664
Nicholas P. D. Liau Australia 9 353 1.2× 370 1.4× 281 1.8× 71 1.3× 12 0.3× 14 781
Joseph M. Cantor United States 13 308 1.1× 127 0.5× 273 1.7× 60 1.1× 13 0.3× 21 699
Chunfai Lai United States 10 212 0.7× 218 0.8× 230 1.4× 75 1.4× 15 0.3× 13 511
David Browell United Kingdom 13 286 1.0× 277 1.0× 76 0.5× 129 2.4× 8 0.2× 26 608

Countries citing papers authored by V. Waldmann

Since Specialization
Citations

This map shows the geographic impact of V. Waldmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Waldmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Waldmann more than expected).

Fields of papers citing papers by V. Waldmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Waldmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Waldmann. The network helps show where V. Waldmann may publish in the future.

Co-authorship network of co-authors of V. Waldmann

This figure shows the co-authorship network connecting the top 25 collaborators of V. Waldmann. A scholar is included among the top collaborators of V. Waldmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Waldmann. V. Waldmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Waldmann, V., J. Wacker, & Martin Deichmann. (2002). Absence of mutations in the pleckstrin homology (PH) domain of protein kinase B (PKB/Akt) in malignant melanoma. Melanoma Research. 12(1). 45–50. 17 indexed citations
2.
Waldmann, V.. (2002). Depth Psychology-based Psychotherapy of Atopic Dermatitis. 3(2). 82–86. 1 indexed citations
3.
Waldmann, V., Martin Deichmann, & Andreas Jäckel. (2001). Disseminierte Melanomzellen in Blut und Knochenmark Bedeutung und Nachweis durch potenzielle Tumormarker. Der Hautarzt. 52(4). 298–303. 1 indexed citations
4.
5.
Waldmann, V., et al.. (2001). Mutations of the activation-associated phosphorylation sites at codons 308 and 473 of protein kinase B are absent in human melanoma. Archives of Dermatological Research. 293(7). 368–372. 15 indexed citations
6.
Waldmann, V., Martin Deichmann, & Andreas Jäckel. (2001). Disseminierte Melanomzellen in Blut und Knochenmark. Der Hautarzt. 52(4). 298–303. 2 indexed citations
7.
Jäckel, Andreas, Michael Bock, Martin Deichmann, V. Waldmann, & H Näher. (2001). Therapie des metastasierten malignen Uveamelanoms. Der Hautarzt. 52(2). 98–103. 14 indexed citations
8.
Waldmann, V., et al.. (2001). Mutations of the PH Domain of Protein Kinase B (PKB/AKT) Are Absentin Human Epidermal Skin Tumors. Dermatology. 203(4). 284–288. 2 indexed citations
9.
Waldmann, V., et al.. (2001). Prognosis of Metastatic Melanoma: No Correlation of Tyrosinase mRNA in Bone Marrow and Survival Time. Recent results in cancer research. 158. 118–125. 7 indexed citations
10.
Waldmann, V., et al.. (2000). No Correlation of Tyrosinase mRNA in Bone Marrow with Prognosis of Metastatic Melanoma. Dermatology. 201(1). 6–9. 2 indexed citations
11.
Jäckel, Andreas, Martin Deichmann, V. Waldmann, Michael Bock, & Helmut Näher. (1999). S-100β-Protein im Serum als Tumormarker beim malignen Melanom Aktueller Kenntnisstand und klinische Erfahrungen. Der Hautarzt. 50(4). 250–256. 12 indexed citations
12.
Waldmann, V., et al.. (1999). Pathogenese des malignen Melanoms. Der Hautarzt. 50(6). 398–405. 6 indexed citations
13.
Jäckel, Andreas, Martin Deichmann, V. Waldmann, Michael Bock, & Helmut Näher. (1999). S-100β-Protein im Serum als Tumormarker beim malignen Melanom. Der Hautarzt. 50(4). 250–256. 16 indexed citations
14.
Deichmann, Martin, Axel Benner, Michael Bock, et al.. (1999). S100-Beta, Melanoma-Inhibiting Activity, and Lactate Dehydrogenase Discriminate Progressive From Nonprogressive American Joint Committee on Cancer Stage IV Melanoma. Journal of Clinical Oncology. 17(6). 1891–1891. 168 indexed citations
15.
Suchy, Bernhard, et al.. (1998). Absence of RAS and p53 mutations in thyroid carcinomas of children after Chernobyl in contrast to adult thyroid tumours. British Journal of Cancer. 77(6). 952–955. 58 indexed citations
16.
Deichmann, Martin, Burkhard Helmke, Markus Böck, et al.. (1998). Massive lethal cerebral bleeding in a patient with melanoma without intracranial metastasis. Clinical Oncology. 10(4). 272–273. 3 indexed citations
17.
Scheibenbogen, Carmen, Stefan Stevanović, Mathias Witzens‐Harig, et al.. (1997). Analysis of the T cell response to tumor and viral peptide antigens by an IFNγ-ELISPOT assay. International Journal of Cancer. 71(6). 932–936. 90 indexed citations
18.
Waldmann, V. & H. Rabes. (1996). What's New in Ras Genes?. Pathology - Research and Practice. 192(9). 883–891. 20 indexed citations
19.
Waldmann, V. & H. Rabes. (1996). Proliferative heterogeneity of human renal cell carcinomas and prevalence ofras gene point mutations. Journal of Cancer Research and Clinical Oncology. 122(4). 207–213. 3 indexed citations
20.
Waldmann, V., Bernhard Suchy, & H. Rabes. (1993). Cell proliferation and prevalence of ras gene mutations in 7,12-dimethylbenz(a)anthracene (DMBA)-induced rat mammary tumors. Research in Experimental Medicine. 193(1). 143–151. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Kaufmann Breakdown of academic impact, for papers by David W. Houck Breakdown of academic impact, for papers by Sophie Goddard Breakdown of academic impact, for papers by Vipul Bhargava Breakdown of academic impact, for papers by Shahryar Kiaii Breakdown of academic impact, for papers by Paul W. Hollenbach Breakdown of academic impact, for papers by Nicholas P. D. Liau Breakdown of academic impact, for papers by Joseph M. Cantor Breakdown of academic impact, for papers by Chunfai Lai Breakdown of academic impact, for papers by David Browell
Rankless by CCL
2026